DrugPatentWatch Database Preview
Vericel Corporation Company Profile
Email this page to a colleague
» See Plans and PricingUS Patents for Vericel Corporation
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vericel Corporation | MACI | autologous cultured chondrocytes | IMPLANT | 125603 | 001 | 2017-01-11 | 10,016,338 | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | search | ||
| Vericel Corporation | MACI | autologous cultured chondrocytes | IMPLANT | 125603 | 001 | 2017-01-11 | 10,239,927 | Novartis AG (Basel, CH) | 2039-10-24 | search | ||
| Vericel Corporation | MACI | autologous cultured chondrocytes | IMPLANT | 125603 | 001 | 2017-01-11 | 10,328,126 | Novartis AG (Basel, CH) | 2033-03-08 | search | ||
| Vericel Corporation | MACI | autologous cultured chondrocytes | IMPLANT | 125603 | 001 | 2017-01-11 | 10,533,042 | NOVARTIS AG (Basel, CH) | 2040-01-15 | search | ||
| Vericel Corporation | MACI | autologous cultured chondrocytes | IMPLANT | 125603 | 001 | 2017-01-11 | 10,577,154 | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2029-05-13 | search | ||
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
